Cargando…
Comprehensive clinical, biochemical, radiological and genetic analysis of 28 Turkish cases with suspected metachromatic leukodystrophy and their relatives
Metachromatic leukodystrophy (MLD) is a glycosphingolipid storage disease caused by deficiency of the lysosomal enzyme arylsulfatase A (ASA) or its activator protein saposin B. MLD can affect all age groups in severity varying from a severe fatal form to milder adult onset forms. Diagnosis is usuall...
Autores principales: | Pekgül, Faruk, Eroğlu-Ertuğrul, Nesibe Gevher, Bekircan-Kurt, Can Ebru, Erdem-Ozdamar, Sevim, Çetinkaya, Arda, Tan, Ersin, Konuşkan, Bahadır, Karaağaoğlu, Ergun, Topçu, Meral, Akarsu, Nurten Ayşe, Oguz, Kader K., Anlar, Banu, Özkara, Hatice Asuman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734308/ https://www.ncbi.nlm.nih.gov/pubmed/33335837 http://dx.doi.org/10.1016/j.ymgmr.2020.100688 |
Ejemplares similares
-
Intrathecal baclofen in metachromatic leukodystrophy
por: van der Veldt, Nikki, et al.
Publicado: (2018) -
Developing therapeutic approaches for metachromatic leukodystrophy
por: Patil, Shilpa A, et al.
Publicado: (2013) -
Diffusion tensor imaging in metachromatic leukodystrophy
por: van Rappard, Diane F., et al.
Publicado: (2018) -
Acetobacter indonesiensis Bacteremia in Child with Metachromatic Leukodystrophy
por: Kohlmann, Rebekka, et al.
Publicado: (2016) -
Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches
por: Shaimardanova, Alisa A., et al.
Publicado: (2020)